Published: Last Year Category: All Categories Life Sciences Biotechnology Antisense & RNAi Technology -
Rnai Technology Market, By Application (Drug Discovery and Development, Therapeutics, Functional Genomics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene silencing mediated by short interfering RNAs (siRNAs) or microRNAs (miRNAs). It has emerged as a powe ... Read More
-
Antisense and RNAi Therapeutics
Global Antisense and RNAi Therapeutics Market to Reach US$3.6 Billion by 2030 The global market for Antisense and RNAi Therapeutics estimated at US$2.2 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Antisense RNA, ... Read More
-
Need some help finding the right information ?Verify before you buy
or call us
US toll free: 800.298.5699
Worldwide: +1.240.747.3093
-
RNA Interference (RNAi)
Global RNA Interference (RNAi) Market to Reach US$206.7 Billion by 2030 The global market for RNA Interference (RNAi) estimated at US$116.7 Billion in the year 2024, is expected to reach US$206.7 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Drug Discovery & Dev ... Read More
-
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market, By Type (Hereditary Transthyretin Amyloidosis (hATTR), Wild Type Transthyretin Amyloidosis (wtATTR)), By Drug Type (Transthyretin Stabilizers, Nonsteroidal Anti-Inflammatory Drugs (NSAID), RNAi Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a common type of amyloidosis, which affects the heart, causing heart muscles to stiffen and eventually lead to heart failure. ATTR-CM often causes symptoms of heart failure, such as fatigue, shortness of breath and peripheral edema, and other symptom ... Read More
-
Antisense & RNAi Therapeutics Global Market Report 2025
Antisense & RNAi Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on antisense & rnai therapeutics market which is experiencing strong grow ... Read More
-
RNA Interference (RNAi) Drug Delivery Market Report by Application (Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others), Technology (Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, Aptamer Drug Delivery), and Region 2025-2033
The global RNA interference (RNAi) drug delivery market size reached USD 99.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 466.1 Billion by 2033, exhibiting a growth rate (CAGR) of 17.75% during 2025-2033. Ribonucleic acid interference (RNAi) drug delivery refers to ... Read More
-
Antisense Oligonucleotides Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Market Overview The Antisense Oligonucleotides (ASOs) Market was valued at USD 2,928.00 million in 2024 and is projected to reach USD 8,063.76 million by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2032. The market is experiencing significant growth due to several key ... Read More
-
2025 Global Forecast for Antisense And Rnai Therapeutics Market (2026-2031 Outlook)-High Tech Outlook Report
The 2025 Global Forecast for Antisense And Rnai Therapeutics Market (2026-2031 Outlook)-High Tech Outlook Report , published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 50 countries. The product or service category is within the NAICS Medic ... Read More
-
2025 Global: Antisense And Rnai Therapeutics Market - Innovative Markets Forecast (2031) report
The 2025 Global: Antisense And Rnai Therapeutics Market - Innovative Markets Forecast (2031) report analyzies the market size, projected growth/decline and regional data for the period 2020 through 2031. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprieta ... Read More
-
Global RNA Interference (RNAi) Drug Delivery Market Growth 2024-2030
Global RNA Interference (RNAi) Drug Delivery Market Growth 2024-2030 According to our LPI (LP Information) latest study, the global RNA Interference (RNAi) Drug Delivery market size was valued at US$ million in 2023. With growing demand in downstream market, the RNA Interference (RNAi) Drug Delivery ... Read More
-
Global Antisense & RNAi Therapeutics Market Growth (Status and Outlook) 2024-2030
Global Antisense & RNAi Therapeutics Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Antisense & RNAi Therapeutics market size was valued at US$ 937.7 million in 2023. With growing demand in downstream market, the Antisense & RNAi Therapeut ... Read More
-
RNA Interference (RNAi) Pesticides Market Forecasts to 2030 – Global Analysis By Type (Synthetic RNAi Pesticides and Natural RNAi Pesticides), Mode of Action (Gene Silencing and RNA Interference), Crop Type, Application, End User and By Geography
RNA Interference (RNAi) Pesticides Market Forecasts to 2030 – Global Analysis By Type (Synthetic RNAi Pesticides and Natural RNAi Pesticides), Mode of Action (Gene Silencing and RNA Interference), Crop Type, Application, End User and By Geography According to Stratistics MRC, the Global RNA Interfer ... Read More
-
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Clinical and Commercial), Therapeutic Area (Cardiovascular Disorders, Genetic Disorders, Liver Disorders, Rare Diseases, and Other Disorders), End-Users (Pharmaceutical / Biopharmaceutical Companies, Academic and Research Institutes, and Hospitals), Company Size (Small, Mid-sized, and Large and Very Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Cl ... Read More
-
Global Longevity and Anti-senescence Therapy Market 2025-2029
Longevity And Anti-Senescence Therapy Market 2025-2029 The longevity and anti-senescence therapy market is forecasted to grow by USD 9.5 bn during 2024-2029, accelerating at a CAGR of 5.2% during the forecast period. The report on the longevity and anti-senescence therapy market provides a holistic ... Read More
-
Global Antisense & RNAi Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Global Antisense & RNAi Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030 According to our (Global Info Research) latest study, the global Antisense & RNAi Therapeutics market size was valued at USD 986.3 million in 2023 and is forecast to a readjusted size of USD ... Read More
-
RNAi Technologies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
RNAi Technologies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type This report describes the global market size of RNAi Technologies from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the ... Read More
-
RNAi for Therapeutic Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
RNAi for Therapeutic Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type This report describes the global market size of RNAi for Therapeutic from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size ... Read More
-
Antisense & RNAi Therapeutics – A Global Market Overview
Antisense & RNAi Therapeutics – A Global Market Overview Antisense & RNAi Therapeutics Market Trends and Outlook Antisense and RNA interference (RNAi) therapeutics are novel approaches to inhibit gene expression to treat diseases. Antisense therapy utilizes synthetic nucleic acids called ant ... Read More
-
RNAi Pesticides Market - A Global and Regional Analysis: Focus on Application, Product, and Competitive Landscape - Analysis and Forecast, 2024-2034
RNAi Pesticides Market - A Global and Regional Analysis: Focus on Application, Product, and Competitive Landscape - Analysis and Forecast, 2024-2034 Introduction to RNAi Pesticides Market The RNAi Pesticides Market is a rapidly evolving segment within the broader agricultural industry, focusing on i ... Read More
-
Global RNAi Technologies Market Research Report 2024(Status and Outlook)
Global RNAi Technologies Market Research Report 2024(Status and Outlook) Report Overview: RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small ... Read More
-
Global Microrna (mirna) Market 2024-2028
Microrna (MIRNA) Market 2024-2028 The microrna (MIRNA) market is forecasted to grow by USD 3186.2 mn during 2023-2028, accelerating at a CAGR of 23.31% during the forecast period. The report on the microrna (MIRNA) market provides a holistic analysis, market size and forecast, trends, growth drivers ... Read More
-
Global RNA Based Therapeutics Market 2024-2028
Global RNA Based Therapeutics Market 2024-2028 RNA Based Therapeutics Market 2024-2028 The RNA based therapeutics market is forecasted to grow by USD 1268.2 mn during 2023-2028, accelerating at a CAGR of 5.54% during the forecast period. The report on the RNA based therapeutics market provides a hol ... Read More
-
Global Nucleic Acid Therapeutics Market Size study, by Product (Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi), RNA Aptamers), by Indication (Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, Others), by End-user (Hospitals, Physicians’ Offices, Others), and Regional Forecasts 2022-2032
Global Nucleic Acid Therapeutics Market Size study, by Product (Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi), RNA Aptamers), by Indication (Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, Others), by End-user (Hospitals, Physicians’ Offices, Others), and Regional ... Read More
-
Global RNAi-based Biopesticides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Global RNAi-based Biopesticides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 RNA interference (RNAi) is a biological process where RNA molecules inhibit gene expression by neutralizing targeted mRNA molecules. RNAi-based biopesticides leverage this mechanism to contr ... Read More
-
Antisense & RNAi Therapeutics Market Report by Technology (RNA Interference, Antisense RNA), Route of Administration (Intravenous Route, Subcutaneous Route, Intrathecal Route, Pulmonary Delivery, Intraperitoneal Injection, and Others), Application (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Renal Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, and Others), and Region 2024-2032
Antisense & RNAi Therapeutics Market Report by Technology (RNA Interference, Antisense RNA), Route of Administration (Intravenous Route, Subcutaneous Route, Intrathecal Route, Pulmonary Delivery, Intraperitoneal Injection, and Others), Application (Oncology, Cardiovascular Diseases (CVDs), Respirato ... Read More
Research Assistance